EVERYTHING ABOUT RAW MATERIALS

“The existing situation has uncovered some structural weaknesses during the EU’s medicines offer chain and also a substantial dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides reported. She advisable that provide chain concerns be addressed within an EU pharmaceutical method expected to generally be introduced